Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
145
/
QuVa Pharma, Inc.

145

•QuVa Pharma, Inc.•March 24, 2017

FDA 145 - QuVa Pharma, Inc. - March 24, 2017

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This 145 record concerns QuVa Pharma, Inc., with an inspection on March 24, 2017, covering drugs.

Company: QuVa Pharma, Inc.
Inspection Date: March 24, 2017
Product Type: Drugs
Person: Jason Schilling (Special Projects Team Lead)

Open in Dashboard

ID · 10ece0b1-0003-41fb-b907-d82c82da8b1b

Violation Codes2

21 CFR 20.64(d)(3)21 CFR 20

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA 145 - QuVa Pharma, Inc. - March 24, 2017 | Global Key Solutions